Navigation Links
Translational Sciences Corporation to Launch OncoTrac™ at the American Society of Clinical Oncology (ASCO) Annual Meeting
Date:6/1/2011

BOSTON and CHICAGO, June 1, 2011 /PRNewswire/ -- Translational Sciences Corp. (TSC) will launch OncoTracfor Clinical Research at the America Society of Clinical Oncology (ASCO), June 4-6, at Chicago's McCormick Place, Booth #22114. The OncoTrac™ family of software products provides a structured workflow solution for clinicians to report precise measurement of solid and metastatic tumor progression.

OncoTrac™ for Clinical Research enterprise software facilitates tumor response assessment using widely accepted standards such as RECIST 1.0, RECIST 1.1, and WHO, as well as emerging standards such as the Choi criteria. Assessments using these criteria are commonly required by clinical trial protocols and are often submitted as primary and secondary end-point data in new anti-cancer FDA drug approval applications. Yet, not all clinical cancer research reports tumor response correctly with regard to these standards. OncoTrac™is designed to assure conformity to these standards and aid compliance with established clinical research standards including FDA Good Clinical Practice (GCP) and Part 11 Electronic Medical Records. Subject assessment data are integrated into existing research workflows, thereby providing capabilities comparable to those performed at core imaging laboratories in support of drug applications.

Medical imaging techniques such as CT and MRI produce very large data sets that are typically displayed as images and read by clinicians. Often times, subtle but clinically significant findings can be difficult to visualize and computational analysis has been demonstrated to assist precise identification or measurement of disease. The routine implementation of RECIST as a research standard is a clear example,” said Howard Pinsky, CEO of Translational Sciences Corp.  “Recently, the Radiological Society of North America (RSNA), the world’s largest professional radiology society, has made a significant commitment to the integration of quantitative imaging into radiology practice -- an ambitious goal requiring development and deployment of dedicated software like OncoTrac™.”

ABOUT TRANSLATIONAL SCIENCES

Headquartered in Cambridge, Massachusetts, Translational Sciences Corp. (TSC) is a medical software company dedicated to adding value to medical imaging studies, increasing physician efficiency, and improving patient management.Contact:

Anthony Grise +1.877.219.3940 asgrise@transcicorp.com
'/>"/>

SOURCE Translational Sciences Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Translational Science Expert, Dr. Melissa Ashlock, Joins aTyr Pharma to Advance Physiocrine-based Therapeutics
2. Janet Hammond Joins Roche as Vice President, Translational Medicine - Virology
3. AndroScience Corporation Awarded a $3.8 Million, 3-Year Milestone-Driven, Cooperative Translational Research Grant from the NIH to Develop an Oral Treatment for Spinal Bulbar Muscular Atrophy (Kennedys Disease)
4. Research Published in Science Translational Medicine Underscores Value of Depression Gene Therapy License Held by Neurologix
5. Childrens Hospital Boston and Particle Sciences Cooperate on Translational Medicine Efforts
6. Mike Burgess Named Head of Oncology Discovery Translational Area for Roches Pharma Research and Early Development (pRED) Organization
7. The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies
8. CTMM Becomes One of the Worlds Largest Public-Private Partnerships in Translational Medical Research
9. Adlyfe Strikes Translational Medicine Partnership With Wyeth Pharmaceuticals for Alzheimers Biomarker Assay
10. Oncolytics Biotech Inc. Announces Start of Patient Enrolment in Translational Clinical Trial Investigating REOLYSIN(R) in Patients with Metastatic Colorectal Cancer
11. Michael J. Fox Foundation Announces $11 Million in 2009 Funding for Translational, Pre-Clinical and Clinical Parkinsons Disease Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)...  True Health, a leader in integrated diagnostics ... National Breast Cancer Awareness month to educate doctors ... Research recently published in ... than 10 million American women are at significant ... BRCA2 and have not had testing. These mutations can ...
(Date:10/5/2017)...  In response to the nationwide opioid epidemic, ... (AAOMS) released prescribing recommendations that urge ibuprofen – ... a first-line therapy to manage a patient,s acute ... Recognizing the value and importance of the ... Acute and Postoperative Pain Management" stresses that practitioners ...
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and ... financial results for the third quarter of 2017 on ... conference call on that day with the investment community ... The conference call will begin at 9 ... can access a live webcast of the conference call ...
Breaking Medicine Technology:
(Date:10/13/2017)... Las Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... of 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum ... CBD dose required and providing a CBD form that can be easily incorporated into ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Lori R. Somekh, ... member of ElderCounsel, a national organization of elder law and special needs planning attorneys. ... and rules. It also provides a forum to network with elder law attorneys nationwide,” ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term ... long-term care insurance companies have a waiver for care if the client has a ... when the family pays for care, is often waived, so the benefits from their ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... one of the most popular and least understood books in the Holy Scriptures, Revelation. ... descriptions that have baffled scholars for centuries. Many have tossed it off as mere ...
Breaking Medicine News(10 mins):